Cetera Investment Advisers Sangamo Therapeutics, Inc Transaction History

Cetera Investment Advisers

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$5.23 - $7.82 $441,176 - $659,656	-84,355 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $328 - $493	-45 Reduced 0.05%	84,355 $633,000
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $200,137 - $313,634	18,395 Added 27.87%	84,400 $1.06 Million
Q4 2020 Feb 17, 2021	BUY	$9.23 - $18.18 $609,226 - $1.2 Million	66,005 New	66,005 $1.03 Million

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $183M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

Stay updated on Cetera Investment Advisers with notifications on news.